163 related articles for article (PubMed ID: 15221100)
1. [Public health research with statutory health insurance drug data].
Janhsen K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):521-5. PubMed ID: 15221100
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacoepidemiology. Analysis of drug prescription data].
Gothe H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1145-54. PubMed ID: 18985408
[TBL] [Abstract][Full Text] [Related]
3. A survey of population-based drug databases in Canada.
Miller E; Blatman B; Einarson TR
CMAJ; 1996 Jun; 154(12):1855-64. PubMed ID: 8653645
[TBL] [Abstract][Full Text] [Related]
4. [Data sources for continual quality improvement in medical rehabilitation- the QS-Reha procedure of the statutory health insurance funds and the Eva-Reha documentation system of MDK Rhineland-palatinate].
Bassler M; Nosper M; Follert P; Böwering L; Polak U
Rehabilitation (Stuttg); 2007 Jun; 46(3):155-63. PubMed ID: 17582556
[TBL] [Abstract][Full Text] [Related]
5. Data safety and drug safety in Germany: a closing gap?
Rathmann W
Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):625-30. PubMed ID: 11980251
[TBL] [Abstract][Full Text] [Related]
6. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
[TBL] [Abstract][Full Text] [Related]
7. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
[TBL] [Abstract][Full Text] [Related]
8. Drug utilization studies within the VIDEOFAR project.
Maggini M; Menniti Ippolito F; Spila Alegiani S; Traversa G; Fortini M
Ann Ist Super Sanita; 1991; 27(2):201-6. PubMed ID: 1755571
[TBL] [Abstract][Full Text] [Related]
9. Postmarketing surveillance and other epidemiologic uses of drug prescription data in the United States.
Strom BL
Ann Ist Super Sanita; 1991; 27(2):235-7. PubMed ID: 1755576
[TBL] [Abstract][Full Text] [Related]
10. Information systems for the analysis of drug prescriptions in Spain.
Ferrando MC
Ann Ist Super Sanita; 1991; 27(2):213-6. PubMed ID: 1755573
[TBL] [Abstract][Full Text] [Related]
11. [Health services research based on routine data generated by the SHI. Potential uses of health insurance fund data in health services research].
Schubert I; Köster I; Küpper-Nybelen J; Ihle P
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1095-105. PubMed ID: 18985403
[TBL] [Abstract][Full Text] [Related]
12. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.
; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370
[No Abstract] [Full Text] [Related]
13. [The significance of quality of life from a socio-legal perspective].
Axer P
Z Evid Fortbild Qual Gesundhwes; 2014; 108(2-3):130-9. PubMed ID: 24780711
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study.
Ahrens W; Hagemeier C; Mühlbauer B; Pigeot I; Püntmann I; Reineke A; Steinbach M; Timm J
Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1298-307. PubMed ID: 17957709
[TBL] [Abstract][Full Text] [Related]
15. [Validation of secondary data. Strengths and limitations].
Hoffmann F; Andersohn F; Giersiepen K; Scharnetzky E; Garbe E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1118-26. PubMed ID: 18985405
[TBL] [Abstract][Full Text] [Related]
16. [Work and Health. Representative work-related health monitoring with sickness absence data of the company health insurance in Germany].
Zoike E; Bödeker W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1155-63. PubMed ID: 18985409
[TBL] [Abstract][Full Text] [Related]
17. [Social inequalities in health. Analysis using data from statutory health insurance companies].
Geyer S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1164-72. PubMed ID: 18985410
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacoepidemiological research with large health databases].
Andersohn F; Garbe E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1135-44. PubMed ID: 18985407
[TBL] [Abstract][Full Text] [Related]
19. [Using claims data for small area analysis and controlling of hospital care].
Swart E; Deh U; Robra BP
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1183-92. PubMed ID: 18985412
[TBL] [Abstract][Full Text] [Related]
20. Drug utilization studies and drug monitoring in The Netherlands.
Haaijer-Ruskamp FM; de Jong-van den Berg LT
Ann Ist Super Sanita; 1991; 27(2):217-23. PubMed ID: 1755574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
